FASS logotyp
Receptbelagd

Peka på symbolerna och beteckningarna till vänster för en förklaring.

Kontakt

Sök apotek med läkemedlet i lager

Sök lagerstatus

Serevent® Diskus®

GlaxoSmithKline

Inhalationspulver, avdelad dos 50 mikrog/dos
(Inhalationspulver)

Bronkdilaterande medel vid astma och KOL

Aktiv substans:
ATC-kod: R03AC12
Läkemedel från GlaxoSmithKline omfattas av Läkemedelsförsäkringen.
  • Vad är miljöinformation?

Miljöinformation

Miljöpåverkan

Salmeterol

Miljörisk: Användning av salmeterol har bedömts medföra försumbar risk för miljöpåverkan.
Nedbrytning: Salmeterol är potentiellt persistent.
Bioackumulering: Salmeterol har låg potential att bioackumuleras.


Läs mer

Detaljerad miljöinformation

Environmental Risk Classification

Predicted Environmental Concentration (PEC)

PEC is calculated according to the following formula:

PEC (μg/L) = (A*109*(100-R))/(365*P*V*D*100) = 1.37*10-6*A(100-R)

PEC = 1.00 x 10-4 μg/L


Where:

A = 0.73 kg (total sold amount API in Sweden year 2023, data from IQVIA). Reduction of A may be justified based on metabolism data.

R = 0% removal rate (conservatively, it has been assumed there is no loss by adsorption to sludge particles, by volatilization, hydrolysis or biodegradation)

P = number of inhabitants in Sweden = 10 *106

V (L/day) = volume of wastewater per capita and day = 200 (ECHA default) (Ref. I)

D = factor for dilution of waste water by surface water flow = 10 (ECHA default) (Ref. I)


Predicted No Effect Concentration (PNEC)

Ecotoxicological studies


Green Algae (Scenedesmus subspicatus):

IC50 96h (inhibition) = 2,800 μg/L (OECD 201) (Reference 3)

NOEC = 1,300 μg/L


Water flea (Daphnia magna):

Acute toxicity

EC50 48 h (immobility) = 13,800 μg/L (OECD 202) (Reference 10)


Water flea (Ceriodaphnia dubia):

Chronic toxicity

NOEC 8 days (reproduction) = 1,100 μg/L (USEPA 1002) (Reference 6)


Rainbow Trout (Oncorhyncus mykiss):

Acute toxicity

LC50 96 h (lethality) = 24,000 μg/L (OECD 203) (Reference 5)


Fathead minnow, Pimephales promelas:

Chronic toxicity

No data


Other ecotoxicity data:

Microorganisms in activated sludge:

EC50 3 h (inhibition) > 688,000 μg/L (OECD 209) (Reference 10)


Terrestrial toxicity

Manure worm (Eisenia foetida):

LC50 28d = 230,000 μg/kg (TAD 4.12) (Reference 8)


PNEC = 1,100/50 = 22 μg/L

PNEC (μg/L) = lowest NOEC/50, where 50 is the assessment factor applied for two long-term NOECs. NOEC for water flea (= 1,100 ug/L) has been used for this calculation since it is the most sensitive of the three tested species.


Environmental risk classification (PEC/PNEC ratio)

PEC/PNEC = 1.00 x 10-4/22 = 4.55 x 10-6, i.e. PEC/PNEC ≤ 0.1 which justifies the phrase “Use of salmeterol has been considered to result in insignificant environmental risk.”


Degradation

Biotic degradation


Ready degradability:

No data


Inherent degradability:

50% degradation in 12.80 days (TAD 3.11). (Reference 10)


Soil metabolism:

29.9 to 49.9% degradation in 64 days (OECD 304) (Reference 9)


Abiotic degradation

Hydrolysis:

50% degradation > 1 year (TAD 3.09). (Reference 10)


Photolysis:

No data


Justification of chosen degradation phrase:

Salmeterol is not readily degradable but it is inherently primarily degradable in that removal of the parent API in the Sewage Treatment Plant is expected to a significant extent. The phrase “Salmeterol is potentially persistent” is thus chosen.


Bioaccumulation

Partitioning coefficient:

Log Dow = 1.71 at pH 7 (TAD 3.02). (Reference 4)


Log Dow at pH 5 = 2.06

Log Dow at pH 7 = 1.71

Log Dow at pH 9 = 1.32


Justification of chosen bioaccumulation phrase:

Since log Dow < 4 at pH 7, the substance has low potential for bioaccumulation.


Excretion (metabolism)

Salmeterol is extensively metabolised to a pharmacologically inactive 17 metabolite 1-hydroxy-2-naphthoic acid (xinafoate). The major route of excretion of drug related material is via the faeces, 25-60%. (Reference 2).


PBT/vPvB assessment

Salmeterol does not fulfil the criteria for PBT and/or vBvP.

All three properties, i.e. ‘P’, ‘B’ and ‘T’ are required in order to classify a compound as PBT (Reference 1). Salmeterol does not fulfil the criteria for PBT and/or vBvP based on log Dow < 4.


Please, also see Safety data sheets on http://www.msds-gsk.com/ExtMSDSlist.asp.


References


  1. ECHA, European Chemicals Agency. 2008 Guidance on information requirements and chemical safety assessment.

  2. Product Information: Serevent(R) Diskus(R), Salmeterol inhalation powder. GlaxoSmithKline, Research Triangle Park, NC, 2003a.

  3. Vryenhoef V and McKenzie J. Salmeterol Xinafoate: Algal Inhibition Test. Report No. 1127/547. Safepharm Laboratories Limited, April 2005.

  4. Hartley DR. Salmeterol hydroxynapththoate: Determination of the n-Octanol/Water Partition Coefficient following FDA Technical Assisstance Document 3.02. Report No. 92-2-4102. Springborn laboratories, Inc, April 1992.

  5. Sewell IG and McKenzie J. Salmeterol Xinafoate: Acute Toxicity to Rainbow Trout. Report No. 1127/546. Safepharm Laboratories Limited, April 2005.

  6. Wetton PM Salmeterol Xinafoate: Daphnid, Ceriodaphnia Dubia Survival and Reproduction Test. Report No. 1127/949. Safepharm Laboratories Limited, March 2006.

  7. Sewell IG and McKenzie J. Salmeterol Xinafoate: Acute Toxicity to Rainbow Trout. Report No. 1127/546. Safepharm Laboratories Limited, April 2005.

  8. Handley JW, Sewell IG and Bartlett AJ. GR33343G: Earthworm Subacute Toxicty Test. Report No. 303/678. Safepharm Laboratories Limited, May 1995.

  9. Secker, RC. GR33343G: Biodegradation in Soil. Report No. WPT/94/243. Pharmaco LSR Ltd, February1995.

  10. Material Safety Data Sheet for Advair HFA. SDS number 126599. GlaxoSmithKline plc, November 2008.